Next Article in Journal
Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study
Previous Article in Journal
Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human Primates
Previous Article in Special Issue
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 188; https://doi.org/10.3390/vaccines10020188
Action Date Notes Link
article xml file uploaded 25 January 2022 10:40 CET Original file -
article xml uploaded. 25 January 2022 10:40 CET Update https://www.mdpi.com/2076-393X/10/2/188/xml
article pdf uploaded. 25 January 2022 10:40 CET Version of Record https://www.mdpi.com/2076-393X/10/2/188/pdf
article html file updated 25 January 2022 10:41 CET Original file -
article html file updated 31 July 2022 05:56 CEST Update https://www.mdpi.com/2076-393X/10/2/188/html
Back to TopTop